US6207646B1
(en)
*
|
1994-07-15 |
2001-03-27 |
University Of Iowa Research Foundation |
Immunostimulatory nucleic acid molecules
|
US20030026782A1
(en)
*
|
1995-02-07 |
2003-02-06 |
Arthur M. Krieg |
Immunomodulatory oligonucleotides
|
US5968542A
(en)
*
|
1995-06-07 |
1999-10-19 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system as a device
|
US7833543B2
(en)
*
|
1995-06-07 |
2010-11-16 |
Durect Corporation |
High viscosity liquid controlled delivery system and medical or surgical device
|
US6413536B1
(en)
|
1995-06-07 |
2002-07-02 |
Southern Biosystems, Inc. |
High viscosity liquid controlled delivery system and medical or surgical device
|
US5736152A
(en)
*
|
1995-10-27 |
1998-04-07 |
Atrix Laboratories, Inc. |
Non-polymeric sustained release delivery system
|
IL118235A0
(en)
*
|
1996-05-13 |
1996-09-12 |
Univ Ben Gurion |
Composition and method for forming biodegradable implants in situ and uses of these implants
|
ES2158611T3
(en)
|
1996-12-20 |
2001-09-01 |
Alza Corp |
COMPOSITION IN INJECTABLE GEL WITH RETARD EFFECT AND PROCEDURE FOR THE PREPARATION OF SUCH COMPOSITION.
|
US6713527B2
(en)
*
|
1997-02-07 |
2004-03-30 |
Queen's University At Kingston |
Anaesthetic bone cement
|
US6630168B1
(en)
*
|
1997-02-20 |
2003-10-07 |
Biomedicines, Inc. |
Gel delivery vehicles for anticellular proliferative agents
|
US6406705B1
(en)
*
|
1997-03-10 |
2002-06-18 |
University Of Iowa Research Foundation |
Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant
|
US6240616B1
(en)
*
|
1997-04-15 |
2001-06-05 |
Advanced Cardiovascular Systems, Inc. |
Method of manufacturing a medicated porous metal prosthesis
|
US10028851B2
(en)
*
|
1997-04-15 |
2018-07-24 |
Advanced Cardiovascular Systems, Inc. |
Coatings for controlling erosion of a substrate of an implantable medical device
|
US8172897B2
(en)
*
|
1997-04-15 |
2012-05-08 |
Advanced Cardiovascular Systems, Inc. |
Polymer and metal composite implantable medical devices
|
US20060025328A1
(en)
*
|
1997-05-28 |
2006-02-02 |
Burns Patrick J |
Compositions suitable for controlled release of the hormone GnRH and its analogs
|
US6051558A
(en)
*
|
1997-05-28 |
2000-04-18 |
Southern Biosystems, Inc. |
Compositions suitable for controlled release of the hormone GnRH and its analogs
|
DK0996426T3
(en)
|
1997-06-05 |
2007-07-02 |
Bertex Pharma Gmbh |
Multiphase System
|
AUPO907697A0
(en)
|
1997-09-09 |
1997-10-02 |
Day, Robert Edward |
Chemical supplementation of bone
|
US6617321B2
(en)
*
|
1997-09-30 |
2003-09-09 |
Eli Lilly And Company |
2-methyl-thieno-benzodiazepine formulation
|
US6733767B2
(en)
*
|
1998-03-19 |
2004-05-11 |
Merck & Co., Inc. |
Liquid polymeric compositions for controlled release of bioactive substances
|
US7128927B1
(en)
*
|
1998-04-14 |
2006-10-31 |
Qlt Usa, Inc. |
Emulsions for in-situ delivery systems
|
BE1011899A6
(en)
*
|
1998-04-30 |
2000-02-01 |
Ucb Sa |
PHARMACEUTICAL USE gelling.
|
DE69932717T2
(en)
|
1998-05-22 |
2007-08-09 |
Ottawa Health Research Institute, Ottawa |
METHODS AND PRODUCTS FOR INDUCING MUCOSAL IMMUNITY
|
US20030022854A1
(en)
|
1998-06-25 |
2003-01-30 |
Dow Steven W. |
Vaccines using nucleic acid-lipid complexes
|
US6693086B1
(en)
*
|
1998-06-25 |
2004-02-17 |
National Jewish Medical And Research Center |
Systemic immune activation method using nucleic acid-lipid complexes
|
US8052982B2
(en)
|
1998-07-20 |
2011-11-08 |
Peptech Animal Health Pty Limited |
Bioimplant formulation comprising lecithin and stearin
|
CN1243543C
(en)
*
|
1998-07-20 |
2006-03-01 |
派普泰克有限公司 |
Bioimplant formulation
|
AU6333499A
(en)
*
|
1998-10-14 |
2000-05-01 |
Cognis Deutschland Gmbh |
Use of nanoscale sterols and sterol esters
|
US6565874B1
(en)
*
|
1998-10-28 |
2003-05-20 |
Atrix Laboratories |
Polymeric delivery formulations of leuprolide with improved efficacy
|
JP2002536966A
(en)
|
1998-12-30 |
2002-11-05 |
ベス・イスラエル・ディーコニス・メディカル・センター・インコーポレーテッド |
Characterization of the calcium channel family
|
EP1154691A4
(en)
*
|
1999-01-05 |
2004-07-07 |
Massachusetts Eye & Ear Infirm |
Targeted transscleral controlled release drug delivery to the retina and choroid
|
US6955661B1
(en)
|
1999-01-25 |
2005-10-18 |
Atrium Medical Corporation |
Expandable fluoropolymer device for delivery of therapeutic agents and method of making
|
US6184011B1
(en)
*
|
1999-03-22 |
2001-02-06 |
Cbd Technologies, Ltd |
Method of releasing solid matrix affinity adsorbed particulates
|
EP2305324B1
(en)
|
1999-03-25 |
2014-09-17 |
Metabolix, Inc. |
Medical devices and applications of polyhydroxyalkanoate polymers
|
US6306425B1
(en)
*
|
1999-04-09 |
2001-10-23 |
Southern Research Institute |
Injectable naltrexone microsphere compositions and their use in reducing consumption of heroin and alcohol
|
GB9910505D0
(en)
|
1999-05-06 |
1999-07-07 |
Electrosols Ltd |
A method and apparatus for manufacturing consumable tablets
|
US6554851B1
(en)
|
1999-05-07 |
2003-04-29 |
Scimed Life Systems, Inc. |
Methods of sealing an injection site
|
ATE479441T1
(en)
|
1999-09-03 |
2010-09-15 |
Brigham & Womens Hospital |
METHODS AND COMPOSITIONS FOR TREATING INFLAMMATORY DISEASES USING CADHERIN-11 MODULATING AGENTS
|
WO2001021163A2
(en)
*
|
1999-09-21 |
2001-03-29 |
Emory University |
Methods and compositions for treating platelet-related disorders using mpl pathway inhibitory agents
|
TW524696B
(en)
*
|
1999-11-10 |
2003-03-21 |
Sumitomo Pharma |
Sustained-release drug formulations
|
DK1248596T3
(en)
|
2000-01-11 |
2007-07-02 |
Bertex Pharma Gmbh |
Implants, particles
|
US6575888B2
(en)
*
|
2000-01-25 |
2003-06-10 |
Biosurface Engineering Technologies, Inc. |
Bioabsorbable brachytherapy device
|
NZ519992A
(en)
*
|
2000-01-28 |
2004-04-30 |
Smithkline Beecham Corp |
Pharmaceutical compositions containing electrospun fiber of polymeric carrier integrated with active agent
|
US7097855B1
(en)
|
2000-01-31 |
2006-08-29 |
Massachusetts Institute Of Technology |
Transdermal thermal polymerization
|
US7074803B2
(en)
*
|
2001-03-02 |
2006-07-11 |
Durect Corporation |
Opioid formulations
|
US20030211974A1
(en)
*
|
2000-03-21 |
2003-11-13 |
Brodbeck Kevin J. |
Gel composition and methods
|
SE516282C2
(en)
*
|
2000-04-04 |
2001-12-10 |
Nobel Biocare Ab |
Implants provided with connection and hole insertion parts and the procedure for such implants
|
US7048541B2
(en)
*
|
2000-04-04 |
2006-05-23 |
Nobel Biocare Ab |
Implant having attachment and hole-insert parts, and method for producing such an implant
|
AU2001253597A1
(en)
*
|
2000-04-12 |
2001-10-30 |
Minerva Biotechnologies Corporation |
Treatment of neurodegenerative disease
|
EP1274459B1
(en)
|
2000-04-19 |
2005-11-16 |
Genentech, Inc. |
Sustained release formulations comprising growth hormone
|
AU7013401A
(en)
|
2000-06-22 |
2002-01-02 |
Univ Iowa Res Found |
Methods for enhancing antibody-induced cell lysis and treating cancer
|
US6767899B1
(en)
|
2000-08-29 |
2004-07-27 |
Leiner Health Services Corp. |
Composition and method for treatment of conditions having an inflammatory component
|
GB0024884D0
(en)
*
|
2000-10-11 |
2000-11-22 |
Astrazeneca Ab |
Method
|
JP2002128697A
(en)
*
|
2000-10-20 |
2002-05-09 |
Nonomura Tomosuke |
Treating and preventing agent for oral cavity
|
WO2005019269A2
(en)
|
2002-11-27 |
2005-03-03 |
Minerva Biotechnologies Corporation |
Techniques and compositions for the diagnosis and treatment of cancer (muc1)
|
ATE481640T1
(en)
*
|
2000-11-27 |
2010-10-15 |
Minerva Biotechnologies Corp |
DIAGNOSTICS, DRUG SCREENING AND TREATMENT FOR CANCER
|
ES2307568T3
(en)
*
|
2000-12-08 |
2008-12-01 |
Coley Pharmaceutical Gmbh |
CPG TYPE NUCLEIC ACIDS AND SAME USE METHODS.
|
US6623761B2
(en)
|
2000-12-22 |
2003-09-23 |
Hassan Emadeldin M. |
Method of making nanoparticles of substantially water insoluble materials
|
CA2439120C
(en)
*
|
2001-02-23 |
2011-07-05 |
Genentech, Inc. |
Erodible polymers for injection
|
EP1372604A2
(en)
*
|
2001-03-22 |
2004-01-02 |
Battelle Memorial Institute |
Manufacturing dissolvable dosage forms
|
US20030050268A1
(en)
*
|
2001-03-29 |
2003-03-13 |
Krieg Arthur M. |
Immunostimulatory nucleic acid for treatment of non-allergic inflammatory diseases
|
US8137699B2
(en)
*
|
2002-03-29 |
2012-03-20 |
Trustees Of Princeton University |
Process and apparatuses for preparing nanoparticle compositions with amphiphilic copolymers and their use
|
WO2002083046A1
(en)
|
2001-04-16 |
2002-10-24 |
Pamela Howard |
Wound dressing system
|
WO2002089767A1
(en)
|
2001-05-03 |
2002-11-14 |
Massachusetts Eye And Ear Infirmary |
Implantable drug delivery device and use thereof
|
CA2449175A1
(en)
|
2001-06-05 |
2002-12-12 |
University Of Chicago |
Use of methylnaltrexone to treat immune suppression
|
US7455657B2
(en)
*
|
2001-06-19 |
2008-11-25 |
Boston Scientific Scimed, Inc |
Method and apparatus to modify a fluid using a selectively permeable membrane
|
US7318931B2
(en)
*
|
2001-06-21 |
2008-01-15 |
Genentech, Inc. |
Sustained release formulation
|
EP1408876A4
(en)
|
2001-06-22 |
2004-09-22 |
Durect Corp |
Zero-order prolonged release coaxial implants
|
SI1446162T1
(en)
*
|
2001-08-17 |
2009-04-30 |
Coley Pharm Gmbh |
Combination motif immune stimulatory oligonucleotides with improved activity
|
US6488952B1
(en)
|
2001-08-28 |
2002-12-03 |
John P. Kennedy |
Semisolid therapeutic delivery system and combination semisolid, multiparticulate, therapeutic delivery system
|
MXPA04002476A
(en)
|
2001-09-14 |
2004-05-31 |
Anthony A Boiarski |
Microfabricated nanopore device for sustained release of therapeutic agent.
|
US7989018B2
(en)
*
|
2001-09-17 |
2011-08-02 |
Advanced Cardiovascular Systems, Inc. |
Fluid treatment of a polymeric coating on an implantable medical device
|
US7285304B1
(en)
*
|
2003-06-25 |
2007-10-23 |
Advanced Cardiovascular Systems, Inc. |
Fluid treatment of a polymeric coating on an implantable medical device
|
US6863683B2
(en)
*
|
2001-09-19 |
2005-03-08 |
Abbott Laboratoris Vascular Entities Limited |
Cold-molding process for loading a stent onto a stent delivery system
|
DK1455593T3
(en)
|
2001-10-06 |
2013-08-26 |
Merial Ltd |
PROCEDURES AND COMPOSITIONS FOR PROMOTING GROWTH AND INJURY IMMUNITY OF YOUNG ANIMALS
|
WO2003034988A2
(en)
*
|
2001-10-19 |
2003-05-01 |
Idexx Laboratories, Inc. |
Injectable compositions for the controlled delivery of pharmacologically active compound
|
US20030125292A1
(en)
*
|
2001-11-07 |
2003-07-03 |
Sean Semple |
Mucoscal vaccine and methods for using the same
|
SE0103765D0
(en)
*
|
2001-11-09 |
2001-11-09 |
Astrazeneca Ab |
New use
|
CA2467239A1
(en)
|
2001-11-14 |
2003-05-22 |
Alza Corporation |
Catheter injectable depot compositions and uses thereof
|
DE10161078A1
(en)
*
|
2001-12-12 |
2003-08-28 |
Achim Goepferich |
Matrices for the stabilization and controlled release of problem drugs
|
US8685427B2
(en)
*
|
2002-07-31 |
2014-04-01 |
Boston Scientific Scimed, Inc. |
Controlled drug delivery
|
US8133501B2
(en)
|
2002-02-08 |
2012-03-13 |
Boston Scientific Scimed, Inc. |
Implantable or insertable medical devices for controlled drug delivery
|
AU2003216424A1
(en)
*
|
2002-02-25 |
2003-10-08 |
Guilford Pharmaceuticals, Inc. |
Phosphorus-containing compounds with polymeric chains, and methods of making and using the same
|
EP1344538A1
(en)
*
|
2002-03-14 |
2003-09-17 |
Degradable Solutions AG |
Porous biodegradable implant material and method for its fabrication
|
JP2005526079A
(en)
*
|
2002-03-15 |
2005-09-02 |
サイプレス バイオサイエンス, インコーポレイテッド |
NE and 5-HT reuptake inhibitors for treating visceral pain syndrome
|
US7074426B2
(en)
*
|
2002-03-27 |
2006-07-11 |
Frank Kochinke |
Methods and drug delivery systems for the treatment of orofacial diseases
|
US8153141B2
(en)
|
2002-04-04 |
2012-04-10 |
Coley Pharmaceutical Gmbh |
Immunostimulatory G, U-containing oligoribonucleotides
|
US20040096498A1
(en)
*
|
2002-04-29 |
2004-05-20 |
Alvin Kershman |
Oral pharmaceutical delivery system with improved sustained release
|
WO2003092665A2
(en)
*
|
2002-05-02 |
2003-11-13 |
Massachusetts Eye And Ear Infirmary |
Ocular drug delivery systems and use thereof
|
HUE027779T2
(en)
|
2002-05-09 |
2016-11-28 |
Brigham & Womens Hospital Inc |
1L1RL-1 as a cardiovascular disease marker
|
US20040013649A1
(en)
*
|
2002-05-10 |
2004-01-22 |
Inex Pharmaceuticals Corporation |
Cancer vaccines and methods of using the same
|
US20040009944A1
(en)
*
|
2002-05-10 |
2004-01-15 |
Inex Pharmaceuticals Corporation |
Methylated immunostimulatory oligonucleotides and methods of using the same
|
US20030224023A1
(en)
*
|
2002-05-29 |
2003-12-04 |
Unilever Home & Personal Care Usa, Division Of Conopco, Inc. |
Cosmetic compositions with hydroxy amine salts of malonic acid
|
US20040001889A1
(en)
|
2002-06-25 |
2004-01-01 |
Guohua Chen |
Short duration depot formulations
|
IL165910A0
(en)
*
|
2002-07-03 |
2006-01-15 |
Pericor Science Inc |
Compositions of hyaluronic acid and methods of use
|
US20070184089A1
(en)
*
|
2002-07-15 |
2007-08-09 |
Alcon, Inc. |
Non-Polymeric Lipophilic Pharmaceutical Implant Compositions for Intraocular Use
|
DK1521573T3
(en)
*
|
2002-07-15 |
2008-03-25 |
Alcon Inc |
Non-polymeric, lipophilic, pharmaceutical implant compositions for intracellular use
|
US7727549B2
(en)
*
|
2002-07-15 |
2010-06-01 |
Alcon, Inc. |
Pharmaceutical compositions for otic use
|
ES2321083T3
(en)
*
|
2002-07-15 |
2009-06-02 |
Alcon, Inc. |
BIOEROSIONABLE FILM FOR THE OPHTHALMIC ADMINISTRATION OF PHARMACOS.
|
IL166418A0
(en)
|
2002-07-31 |
2006-01-15 |
Alza Corp |
Injectable depot compositions and uses thereof
|
US8920826B2
(en)
|
2002-07-31 |
2014-12-30 |
Boston Scientific Scimed, Inc. |
Medical imaging reference devices
|
CA2494400A1
(en)
|
2002-07-31 |
2004-02-05 |
Alza Corporation |
Injectable multimodal polymer depot compositions and uses thereof
|
TW200410714A
(en)
*
|
2002-08-07 |
2004-07-01 |
Smithkline Beecham Corp |
Electrospun amorphous pharmaceutical compositions
|
US8946387B2
(en)
*
|
2002-08-14 |
2015-02-03 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
US8530627B2
(en)
*
|
2002-08-14 |
2013-09-10 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
US8044180B2
(en)
*
|
2002-08-14 |
2011-10-25 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
US8193318B2
(en)
*
|
2002-08-14 |
2012-06-05 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
WO2004016750A2
(en)
*
|
2002-08-14 |
2004-02-26 |
Macrogenics, Inc. |
FcϜRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
|
US8968730B2
(en)
*
|
2002-08-14 |
2015-03-03 |
Macrogenics Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
US8187593B2
(en)
*
|
2002-08-14 |
2012-05-29 |
Macrogenics, Inc. |
FcγRIIB specific antibodies and methods of use thereof
|
DE10238310A1
(en)
*
|
2002-08-21 |
2004-03-04 |
Erich Jaeger Gmbh |
electrode assembly
|
US20030049698A1
(en)
*
|
2002-10-08 |
2003-03-13 |
Wang Timothy C. |
Diagnosis and treatment of gastrointestinal disease
|
US20060003004A1
(en)
*
|
2002-10-25 |
2006-01-05 |
Collegium Pharmaceutical, Inc. |
Pulsatile release compositions of milnacipran
|
US20040121010A1
(en)
*
|
2002-10-25 |
2004-06-24 |
Collegium Pharmaceutical, Inc. |
Pulsatile release compositions of milnacipran
|
MXPA05004588A
(en)
|
2002-10-29 |
2005-12-14 |
Coley Pharmaceutical Group Ltd |
Use of cpg oligonucleotides in the treatment of hepatitis c virus infection.
|
US20060271168A1
(en)
*
|
2002-10-30 |
2006-11-30 |
Klaus Kleine |
Degradable medical device
|
US20080305177A1
(en)
*
|
2002-11-14 |
2008-12-11 |
Alvin Kershman |
Method of administering testosterone
|
WO2004043434A1
(en)
*
|
2002-11-14 |
2004-05-27 |
Shear/Kershman Laboratories, Inc. |
Oral testosterone delivery system with improved sustained release
|
CA2507522C
(en)
|
2002-12-13 |
2015-02-24 |
Durect Corporation |
Oral drug delivery system
|
US7758881B2
(en)
|
2004-06-30 |
2010-07-20 |
Advanced Cardiovascular Systems, Inc. |
Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
|
US8435550B2
(en)
|
2002-12-16 |
2013-05-07 |
Abbot Cardiovascular Systems Inc. |
Anti-proliferative and anti-inflammatory agent combination for treatment of vascular disorders with an implantable medical device
|
US7355008B2
(en)
|
2003-01-09 |
2008-04-08 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
US7960512B2
(en)
|
2003-01-09 |
2011-06-14 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant Fc regions and methods of using same
|
AU2004204817C1
(en)
|
2003-01-13 |
2011-01-20 |
Macrogenics, Inc. |
Soluble FcyR fusion proteins and methods of use thereof
|
EP1592453A1
(en)
*
|
2003-01-28 |
2005-11-09 |
Collegium Pharmaceutical, Inc. |
Multiparticulate compositions of milnacipran for oral administration
|
SI2325302T1
(en)
|
2003-02-11 |
2016-05-31 |
Shire Human Genetic Therapies, Inc. |
Cells that coexpress a sulfatase and a C-formylglycine generating enzyme and methods and uses thereof
|
WO2004073551A2
(en)
*
|
2003-02-18 |
2004-09-02 |
Massachusetts Eye And Ear Infirmary |
Transscleral drug delivery device and related methods
|
EP1594511A2
(en)
*
|
2003-02-20 |
2005-11-16 |
Alcon, Inc. |
Formulations of glucocorticoids to treat pathologic ocular angiogenesis
|
ZA200505989B
(en)
*
|
2003-02-20 |
2006-12-27 |
Alcon Inc |
Use the steroids to treat ocular disorders
|
WO2004078943A2
(en)
*
|
2003-03-04 |
2004-09-16 |
California Institute Of Technology |
Alternative heterocycles for dna recognition
|
DE10312346A1
(en)
*
|
2003-03-20 |
2004-09-30 |
Bayer Healthcare Ag |
Controlled release system
|
US20040235770A1
(en)
*
|
2003-04-02 |
2004-11-25 |
Coley Pharmaceutical Group, Ltd. |
Immunostimulatory nucleic acid oil-in-water formulations and related methods of use
|
CA2534816A1
(en)
|
2003-06-12 |
2004-12-23 |
Evan Newell |
Systems and methods for treating human inflammatory and proliferative diseases and wounds, with fatty acid metabolism inhibitors and/or glycolytic inhibitors
|
KR20060019579A
(en)
*
|
2003-06-13 |
2006-03-03 |
알콘, 인코퍼레이티드 |
Formulations of non-steroidal anti-inflammatory agents to treat pathologic ocular angiogenesis
|
CA2529503A1
(en)
*
|
2003-06-20 |
2004-12-29 |
Royer Biomedical, Inc. |
Drug polymer complexes
|
US20050048123A1
(en)
|
2003-06-26 |
2005-03-03 |
Control Delivery System, Inc. |
In situ gelling drug delivery system
|
AR047552A1
(en)
|
2003-06-26 |
2006-01-25 |
Control Delivery Sys Inc |
SUPPLY SYSTEMS OF BIODEGRADABLE SUSTAINED RELEASE PHARMACOS
|
US20060173171A1
(en)
*
|
2003-08-26 |
2006-08-03 |
Bamdad Cynthia C |
Techniques and compositions for diagnosis and treatment of cancer (muci)
|
US8021331B2
(en)
*
|
2003-09-15 |
2011-09-20 |
Atrium Medical Corporation |
Method of coating a folded medical device
|
US7198675B2
(en)
|
2003-09-30 |
2007-04-03 |
Advanced Cardiovascular Systems |
Stent mandrel fixture and method for selectively coating surfaces of a stent
|
WO2005034979A2
(en)
*
|
2003-10-11 |
2005-04-21 |
Inex Pharmaceuticals Corporation |
Methods and compositions for enhancing innate immunity and antibody dependent cellular cytotoxicity
|
EP1677781A4
(en)
*
|
2003-10-29 |
2008-11-19 |
Idexx Lab Inc |
Salts of pharmacologically active compounds
|
EP2248895B8
(en)
|
2003-12-19 |
2016-09-21 |
Autotelic LLC |
Combination therapy associating a TGF-beta antagonist with a chemotherapeutic agent
|
US20050154343A1
(en)
*
|
2004-01-14 |
2005-07-14 |
Mohinder Singh |
Soft tip applicator for relieving mouth pain
|
US7452730B2
(en)
*
|
2004-01-16 |
2008-11-18 |
California Institute Of Technology |
DNA-binding polymers
|
US8048101B2
(en)
|
2004-02-25 |
2011-11-01 |
Femasys Inc. |
Methods and devices for conduit occlusion
|
US8052669B2
(en)
|
2004-02-25 |
2011-11-08 |
Femasys Inc. |
Methods and devices for delivery of compositions to conduits
|
US9238127B2
(en)
|
2004-02-25 |
2016-01-19 |
Femasys Inc. |
Methods and devices for delivering to conduit
|
US8048086B2
(en)
|
2004-02-25 |
2011-11-01 |
Femasys Inc. |
Methods and devices for conduit occlusion
|
EP1568383A3
(en)
|
2004-02-27 |
2005-11-16 |
Antisense Pharma GmbH |
Use of an oligonucleotide or its active derivative for the preparation of a pharmaceutical composition for inhibiting the formation of metastases in cancer treatment
|
US20070155685A1
(en)
*
|
2004-02-27 |
2007-07-05 |
Karl-Hermann Schlingensiepen |
Pharmaceutical composition
|
SG173322A1
(en)
*
|
2004-04-16 |
2011-08-29 |
Macrogenics Inc Dw Us |
Fc gammad riib - specific antibodies and methods of use thereof
|
PL1745075T3
(en)
|
2004-04-21 |
2013-09-30 |
Brigham & Womens Hospital Inc |
Poly-n-acetyl glucosamine (pnag/dpnag)-binding peptides and methods of use thereof
|
US8163030B2
(en)
*
|
2004-05-06 |
2012-04-24 |
Degradable Solutions Ag |
Biocompatible bone implant compositions and methods for repairing a bone defect
|
MXPA06012601A
(en)
|
2004-05-10 |
2007-05-10 |
Macrogenics Inc |
HUMANIZED FcgammaRIIB SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF.
|
EP1604693A1
(en)
|
2004-06-09 |
2005-12-14 |
Scil Technology GmbH |
In situ forming scaffold, its manufacturing and use
|
US7858115B2
(en)
*
|
2004-06-24 |
2010-12-28 |
Idexx Laboratories |
Phospholipid gel compositions for drug delivery and methods of treating conditions using same
|
US7618651B2
(en)
*
|
2004-06-24 |
2009-11-17 |
Idexx Laboratories |
Pharmaceutical compositions for drug delivery and methods of treating or preventing conditions using same
|
US7854943B2
(en)
*
|
2004-06-24 |
2010-12-21 |
Idexx Laboratories |
Phospholipid gel compositions for drug delivery and methods of treating conditions using same
|
US8568469B1
(en)
|
2004-06-28 |
2013-10-29 |
Advanced Cardiovascular Systems, Inc. |
Stent locking element and a method of securing a stent on a delivery system
|
US8241554B1
(en)
|
2004-06-29 |
2012-08-14 |
Advanced Cardiovascular Systems, Inc. |
Method of forming a stent pattern on a tube
|
US8747879B2
(en)
*
|
2006-04-28 |
2014-06-10 |
Advanced Cardiovascular Systems, Inc. |
Method of fabricating an implantable medical device to reduce chance of late inflammatory response
|
US7971333B2
(en)
*
|
2006-05-30 |
2011-07-05 |
Advanced Cardiovascular Systems, Inc. |
Manufacturing process for polymetric stents
|
US20060020330A1
(en)
*
|
2004-07-26 |
2006-01-26 |
Bin Huang |
Method of fabricating an implantable medical device with biaxially oriented polymers
|
US8747878B2
(en)
|
2006-04-28 |
2014-06-10 |
Advanced Cardiovascular Systems, Inc. |
Method of fabricating an implantable medical device by controlling crystalline structure
|
US8778256B1
(en)
|
2004-09-30 |
2014-07-15 |
Advanced Cardiovascular Systems, Inc. |
Deformation of a polymer tube in the fabrication of a medical article
|
US7731890B2
(en)
*
|
2006-06-15 |
2010-06-08 |
Advanced Cardiovascular Systems, Inc. |
Methods of fabricating stents with enhanced fracture toughness
|
US20060041102A1
(en)
*
|
2004-08-23 |
2006-02-23 |
Advanced Cardiovascular Systems, Inc. |
Implantable devices comprising biologically absorbable polymers having constant rate of degradation and methods for fabricating the same
|
US9283099B2
(en)
|
2004-08-25 |
2016-03-15 |
Advanced Cardiovascular Systems, Inc. |
Stent-catheter assembly with a releasable connection for stent retention
|
US7893034B2
(en)
*
|
2004-09-02 |
2011-02-22 |
Yale University |
Regulation of oncogenes by microRNAs
|
US7229471B2
(en)
*
|
2004-09-10 |
2007-06-12 |
Advanced Cardiovascular Systems, Inc. |
Compositions containing fast-leaching plasticizers for improved performance of medical devices
|
WO2007053135A1
(en)
*
|
2004-09-14 |
2007-05-10 |
Minerva Biotechnologies Corporation |
Methods for diagnosis and treatment of cancer
|
LT2767292T
(en)
|
2004-09-17 |
2016-12-12 |
Durect Corporation |
Sustained Local Anesthetic Composition Containing SAIB
|
CA2581126A1
(en)
|
2004-09-24 |
2006-04-06 |
Rfe Pharma Llc |
Carboxy-amido-triazoles for the localized treatment of ocular diseases
|
US20160106717A1
(en)
|
2004-09-24 |
2016-04-21 |
Gen Pharma Holdings LLC |
Cai-based systems and methods for the localized treatment of uveitis
|
US20060074422A1
(en)
*
|
2004-09-27 |
2006-04-06 |
Story Brooks J |
Suture anchor and void filler combination
|
US20090011116A1
(en)
*
|
2004-09-28 |
2009-01-08 |
Atrium Medical Corporation |
Reducing template with coating receptacle containing a medical device to be coated
|
US9801982B2
(en)
*
|
2004-09-28 |
2017-10-31 |
Atrium Medical Corporation |
Implantable barrier device
|
US8312836B2
(en)
*
|
2004-09-28 |
2012-11-20 |
Atrium Medical Corporation |
Method and apparatus for application of a fresh coating on a medical device
|
US9012506B2
(en)
*
|
2004-09-28 |
2015-04-21 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
US9000040B2
(en)
|
2004-09-28 |
2015-04-07 |
Atrium Medical Corporation |
Cross-linked fatty acid-based biomaterials
|
WO2006036967A1
(en)
|
2004-09-28 |
2006-04-06 |
Atrium Medical Corporation |
Solubilizing a drug for use in a coating
|
US8962023B2
(en)
*
|
2004-09-28 |
2015-02-24 |
Atrium Medical Corporation |
UV cured gel and method of making
|
US8367099B2
(en)
*
|
2004-09-28 |
2013-02-05 |
Atrium Medical Corporation |
Perforated fatty acid films
|
US8173062B1
(en)
|
2004-09-30 |
2012-05-08 |
Advanced Cardiovascular Systems, Inc. |
Controlled deformation of a polymer tube in fabricating a medical article
|
US7875233B2
(en)
|
2004-09-30 |
2011-01-25 |
Advanced Cardiovascular Systems, Inc. |
Method of fabricating a biaxially oriented implantable medical device
|
US8043553B1
(en)
|
2004-09-30 |
2011-10-25 |
Advanced Cardiovascular Systems, Inc. |
Controlled deformation of a polymer tube with a restraining surface in fabricating a medical article
|
EP3173072A1
(en)
*
|
2004-10-01 |
2017-05-31 |
Ramscor, Inc. |
Conveniently implantable sustained release drug compositions
|
US8313763B2
(en)
*
|
2004-10-04 |
2012-11-20 |
Tolmar Therapeutics, Inc. |
Sustained delivery formulations of rapamycin compounds
|
AU2005294382A1
(en)
*
|
2004-10-04 |
2006-04-20 |
Qlt Usa, Inc. |
Ocular delivery of polymeric delivery formulations
|
WO2007024249A2
(en)
|
2004-11-10 |
2007-03-01 |
Macrogenics, Inc. |
Engineering fc antibody regions to confer effector function
|
US8535709B2
(en)
*
|
2004-12-13 |
2013-09-17 |
Southeastern Medical Technologies, Llc |
Agents for controlling biological fluids and methods of use thereof
|
US20060127437A1
(en)
*
|
2004-12-13 |
2006-06-15 |
Misty Anderson Kennedy |
Semisolid system and combination semisolid, multiparticulate system for sealing tissues and/or controlling biological fluids
|
US20070059350A1
(en)
*
|
2004-12-13 |
2007-03-15 |
Kennedy John P |
Agents for controlling biological fluids and methods of use thereof
|
PT1838716E
(en)
*
|
2005-01-05 |
2011-07-15 |
Lilly Co Eli |
Olanzapine pamoate dihydrate
|
DE102005002703C5
(en)
*
|
2005-01-19 |
2013-07-04 |
Heraeus Kulzer Gmbh |
Antibiotic coating of implants and methods for antibiotic coating
|
EP1848489A2
(en)
*
|
2005-02-16 |
2007-10-31 |
Cytori Therapeutics, Inc. |
Resorbable hollow devices for implantation and delivery of therapeutic agents
|
US8524731B2
(en)
*
|
2005-03-07 |
2013-09-03 |
The University Of Chicago |
Use of opioid antagonists to attenuate endothelial cell proliferation and migration
|
US9662325B2
(en)
|
2005-03-07 |
2017-05-30 |
The University Of Chicago |
Use of opioid antagonists to attenuate endothelial cell proliferation and migration
|
US8518962B2
(en)
|
2005-03-07 |
2013-08-27 |
The University Of Chicago |
Use of opioid antagonists
|
MX2007010833A
(en)
*
|
2005-03-07 |
2009-02-17 |
Univ Chicago |
Use of opioid antagonists to attenuate endothelial cell proliferation and migration.
|
EP1875244B1
(en)
*
|
2005-03-30 |
2019-01-23 |
Minerva Biotechnologies Corporation |
Proliferation of muc1 expressing cells
|
DK1875244T3
(en)
|
2005-03-30 |
2019-04-29 |
Minerva Biotechnologies Corp |
Proliferation of MUC1-Expressing Cells
|
US20060224226A1
(en)
*
|
2005-03-31 |
2006-10-05 |
Bin Huang |
In-vivo radial orientation of a polymeric implantable medical device
|
US8864730B2
(en)
|
2005-04-12 |
2014-10-21 |
Rochester Medical Corporation |
Silicone rubber male external catheter with absorbent and adhesive
|
US7381048B2
(en)
*
|
2005-04-12 |
2008-06-03 |
Advanced Cardiovascular Systems, Inc. |
Stents with profiles for gripping a balloon catheter and molds for fabricating stents
|
EP3479844B1
(en)
|
2005-04-15 |
2023-11-22 |
MacroGenics, Inc. |
Covalent diabodies and uses thereof
|
CN101448517A
(en)
|
2005-04-19 |
2009-06-03 |
伊莱利利公司 |
Monovalent and polyvalent synthetic polysaccharide antigens for immunological intervention in disease
|
US20060241076A1
(en)
*
|
2005-04-26 |
2006-10-26 |
Coley Pharmaceutical Gmbh |
Modified oligoribonucleotide analogs with enhanced immunostimulatory activity
|
WO2006119018A2
(en)
*
|
2005-04-29 |
2006-11-09 |
Atrium Medical Corporation |
Drug delivery coating for use with a medical device and methods of treating vascular injury
|
DE602006004578D1
(en)
|
2005-05-05 |
2009-02-12 |
Antisense Pharma Gmbh |
USE OF TGF-BETA2 ANTISENSE OLIGONUCLEOTIDES
|
US20060257448A1
(en)
*
|
2005-05-10 |
2006-11-16 |
The University Of Zurich |
Resorbable polymer composition, implant and method of making implant
|
US7291166B2
(en)
*
|
2005-05-18 |
2007-11-06 |
Advanced Cardiovascular Systems, Inc. |
Polymeric stent patterns
|
US20060282028A1
(en)
*
|
2005-06-10 |
2006-12-14 |
Howard Pamela A |
Wound Management System
|
KR101502920B1
(en)
|
2005-06-21 |
2015-03-17 |
조마 (유에스) 엘엘씨 |
IL-1β Binding antibodies and fragments thereof
|
US8354384B2
(en)
*
|
2005-06-23 |
2013-01-15 |
Yale University |
Anti-aging micrornas
|
US7727235B2
(en)
*
|
2005-06-29 |
2010-06-01 |
Ethicon, Inc. |
Medical fixation devices with improved torsional drive head
|
US20070027105A1
(en)
|
2005-07-26 |
2007-02-01 |
Alza Corporation |
Peroxide removal from drug delivery vehicle
|
US7658880B2
(en)
*
|
2005-07-29 |
2010-02-09 |
Advanced Cardiovascular Systems, Inc. |
Polymeric stent polishing method and apparatus
|
US7297758B2
(en)
*
|
2005-08-02 |
2007-11-20 |
Advanced Cardiovascular Systems, Inc. |
Method for extending shelf-life of constructs of semi-crystallizable polymers
|
SI1919503T1
(en)
|
2005-08-10 |
2015-02-27 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant fc regions and methods of using same
|
US20070038290A1
(en)
*
|
2005-08-15 |
2007-02-15 |
Bin Huang |
Fiber reinforced composite stents
|
US7476245B2
(en)
*
|
2005-08-16 |
2009-01-13 |
Advanced Cardiovascular Systems, Inc. |
Polymeric stent patterns
|
US8362086B2
(en)
|
2005-08-19 |
2013-01-29 |
Merial Limited |
Long acting injectable formulations
|
TW201402124A
(en)
|
2005-08-19 |
2014-01-16 |
Array Biopharma Inc |
8-substituted benzoazepines as toll-like receptor modulators
|
US20070045252A1
(en)
*
|
2005-08-23 |
2007-03-01 |
Klaus Kleine |
Laser induced plasma machining with a process gas
|
US9248034B2
(en)
*
|
2005-08-23 |
2016-02-02 |
Advanced Cardiovascular Systems, Inc. |
Controlled disintegrating implantable medical devices
|
US20070045255A1
(en)
*
|
2005-08-23 |
2007-03-01 |
Klaus Kleine |
Laser induced plasma machining with an optimized process gas
|
EP1957093B1
(en)
|
2005-08-29 |
2017-04-12 |
SHASHOUA, Victor E. |
Neuroprotective and neurorestorative methods and compositions
|
JP5554496B2
(en)
*
|
2005-09-19 |
2014-07-23 |
ニューロナセント インコーポレイテッド |
Methods and compositions for stimulating neurogenesis and for inhibiting neuronal degeneration
|
US9427423B2
(en)
|
2009-03-10 |
2016-08-30 |
Atrium Medical Corporation |
Fatty-acid based particles
|
US8574627B2
(en)
*
|
2006-11-06 |
2013-11-05 |
Atrium Medical Corporation |
Coated surgical mesh
|
US9278161B2
(en)
|
2005-09-28 |
2016-03-08 |
Atrium Medical Corporation |
Tissue-separating fatty acid adhesion barrier
|
US8852638B2
(en)
|
2005-09-30 |
2014-10-07 |
Durect Corporation |
Sustained release small molecule drug formulation
|
US20070134244A1
(en)
*
|
2005-10-14 |
2007-06-14 |
Alcon, Inc. |
Combination treatment for pathologic ocular angiogenesis
|
EP1933991A4
(en)
|
2005-10-15 |
2012-05-02 |
Atrium Medical Corp |
Hydrophobic cross-linked gels for bioabsorbable drug carrier coatings
|
AU2006312407A1
(en)
*
|
2005-11-09 |
2007-05-18 |
Philera New Zealand Limited |
Treatment of mitochondria-related diseases and improvement of age-related metabolic deficits
|
US8658608B2
(en)
*
|
2005-11-23 |
2014-02-25 |
Yale University |
Modified triple-helix forming oligonucleotides for targeted mutagenesis
|
DK1957647T3
(en)
|
2005-11-25 |
2015-04-07 |
Zoetis Belgium S A |
Immunostimulatory oligoribonucleotides
|
US7867547B2
(en)
|
2005-12-19 |
2011-01-11 |
Advanced Cardiovascular Systems, Inc. |
Selectively coating luminal surfaces of stents
|
JP5276448B2
(en)
*
|
2005-12-22 |
2013-08-28 |
オークウッド ラボラトリーズ,エル.エル.シー. |
Sublimable sustained release delivery system and method for producing the same
|
US20070151961A1
(en)
*
|
2006-01-03 |
2007-07-05 |
Klaus Kleine |
Fabrication of an implantable medical device with a modified laser beam
|
US20070156230A1
(en)
*
|
2006-01-04 |
2007-07-05 |
Dugan Stephen R |
Stents with radiopaque markers
|
US7951185B1
(en)
|
2006-01-06 |
2011-05-31 |
Advanced Cardiovascular Systems, Inc. |
Delivery of a stent at an elevated temperature
|
CN101400363B
(en)
|
2006-01-18 |
2012-08-29 |
昌达生物科技公司 |
Pharmaceutical compositions with enhanced stability
|
US20070179219A1
(en)
*
|
2006-01-31 |
2007-08-02 |
Bin Huang |
Method of fabricating an implantable medical device using gel extrusion and charge induced orientation
|
AU2007226752A1
(en)
*
|
2006-03-10 |
2007-09-20 |
Macrogenics, Inc. |
Identification and engineering of antibodies with variant heavy chains and methods of using same
|
CN101442998B
(en)
*
|
2006-03-16 |
2012-03-14 |
比奥纽默里克药物公司 |
Anti-cancer activity augmentation compounds and formulations and methods of use thereof
|
US7964210B2
(en)
*
|
2006-03-31 |
2011-06-21 |
Abbott Cardiovascular Systems Inc. |
Degradable polymeric implantable medical devices with a continuous phase and discrete phase
|
WO2007120638A2
(en)
*
|
2006-04-12 |
2007-10-25 |
President And Fellows Of Harvard College |
Methods and compositions for modulating glycosylation
|
US20070254012A1
(en)
*
|
2006-04-28 |
2007-11-01 |
Ludwig Florian N |
Controlled degradation and drug release in stents
|
US8003156B2
(en)
|
2006-05-04 |
2011-08-23 |
Advanced Cardiovascular Systems, Inc. |
Rotatable support elements for stents
|
US7761968B2
(en)
*
|
2006-05-25 |
2010-07-27 |
Advanced Cardiovascular Systems, Inc. |
Method of crimping a polymeric stent
|
US8752268B2
(en)
|
2006-05-26 |
2014-06-17 |
Abbott Cardiovascular Systems Inc. |
Method of making stents with radiopaque markers
|
US7951194B2
(en)
|
2006-05-26 |
2011-05-31 |
Abbott Cardiovascular Sysetms Inc. |
Bioabsorbable stent with radiopaque coating
|
WO2008105886A2
(en)
|
2006-05-26 |
2008-09-04 |
Macrogenics, Inc. |
HUMANIZED FCγRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
|
US7842737B2
(en)
|
2006-09-29 |
2010-11-30 |
Abbott Cardiovascular Systems Inc. |
Polymer blend-bioceramic composite implantable medical devices
|
US20070282434A1
(en)
*
|
2006-05-30 |
2007-12-06 |
Yunbing Wang |
Copolymer-bioceramic composite implantable medical devices
|
US7959940B2
(en)
*
|
2006-05-30 |
2011-06-14 |
Advanced Cardiovascular Systems, Inc. |
Polymer-bioceramic composite implantable medical devices
|
US8343530B2
(en)
*
|
2006-05-30 |
2013-01-01 |
Abbott Cardiovascular Systems Inc. |
Polymer-and polymer blend-bioceramic composite implantable medical devices
|
US20080058916A1
(en)
*
|
2006-05-31 |
2008-03-06 |
Bin Huang |
Method of fabricating polymeric self-expandable stent
|
US8486135B2
(en)
|
2006-06-01 |
2013-07-16 |
Abbott Cardiovascular Systems Inc. |
Implantable medical devices fabricated from branched polymers
|
US20070281073A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Gale David C |
Enhanced adhesion of drug delivery coatings on stents
|
US20070282433A1
(en)
*
|
2006-06-01 |
2007-12-06 |
Limon Timothy A |
Stent with retention protrusions formed during crimping
|
US8034287B2
(en)
*
|
2006-06-01 |
2011-10-11 |
Abbott Cardiovascular Systems Inc. |
Radiation sterilization of medical devices
|
US20070286941A1
(en)
*
|
2006-06-13 |
2007-12-13 |
Bin Huang |
Surface treatment of a polymeric stent
|
US8603530B2
(en)
|
2006-06-14 |
2013-12-10 |
Abbott Cardiovascular Systems Inc. |
Nanoshell therapy
|
US8048448B2
(en)
|
2006-06-15 |
2011-11-01 |
Abbott Cardiovascular Systems Inc. |
Nanoshells for drug delivery
|
US8535372B1
(en)
|
2006-06-16 |
2013-09-17 |
Abbott Cardiovascular Systems Inc. |
Bioabsorbable stent with prohealing layer
|
US8333000B2
(en)
|
2006-06-19 |
2012-12-18 |
Advanced Cardiovascular Systems, Inc. |
Methods for improving stent retention on a balloon catheter
|
US20070290412A1
(en)
*
|
2006-06-19 |
2007-12-20 |
John Capek |
Fabricating a stent with selected properties in the radial and axial directions
|
CN101472610A
(en)
|
2006-06-20 |
2009-07-01 |
特朗斯吉有限公司 |
Recombinant viral vaccine
|
US8017237B2
(en)
|
2006-06-23 |
2011-09-13 |
Abbott Cardiovascular Systems, Inc. |
Nanoshells on polymers
|
US9072820B2
(en)
*
|
2006-06-26 |
2015-07-07 |
Advanced Cardiovascular Systems, Inc. |
Polymer composite stent with polymer particles
|
WO2008019199A2
(en)
*
|
2006-06-26 |
2008-02-14 |
Macrogenics, Inc. |
FCγRIIB-SPECIFIC ANTIBODIES AND METHODS OF USE THEREOF
|
WO2008002933A2
(en)
*
|
2006-06-26 |
2008-01-03 |
Macrogenics, Inc. |
Combination of fcgammariib antibodies and cd20-specific antibodies and methods of use thereof
|
DE102006029247A1
(en)
*
|
2006-06-26 |
2007-12-27 |
Biotronik Vi Patent Ag |
Implant with a coating comprises one or more components such as cholesterol or cholesterol ester
|
US8128688B2
(en)
|
2006-06-27 |
2012-03-06 |
Abbott Cardiovascular Systems Inc. |
Carbon coating on an implantable device
|
US20070299511A1
(en)
*
|
2006-06-27 |
2007-12-27 |
Gale David C |
Thin stent coating
|
US7794776B1
(en)
|
2006-06-29 |
2010-09-14 |
Abbott Cardiovascular Systems Inc. |
Modification of polymer stents with radiation
|
US7740791B2
(en)
*
|
2006-06-30 |
2010-06-22 |
Advanced Cardiovascular Systems, Inc. |
Method of fabricating a stent with features by blow molding
|
US20080009938A1
(en)
*
|
2006-07-07 |
2008-01-10 |
Bin Huang |
Stent with a radiopaque marker and method for making the same
|
US7823263B2
(en)
|
2006-07-11 |
2010-11-02 |
Abbott Cardiovascular Systems Inc. |
Method of removing stent islands from a stent
|
KR20140109509A
(en)
*
|
2006-07-11 |
2014-09-15 |
큐피에스 엘엘씨 |
Pharmaceutical compositions for sustained release delivery of peptides
|
US7757543B2
(en)
|
2006-07-13 |
2010-07-20 |
Advanced Cardiovascular Systems, Inc. |
Radio frequency identification monitoring of stents
|
US7998404B2
(en)
*
|
2006-07-13 |
2011-08-16 |
Advanced Cardiovascular Systems, Inc. |
Reduced temperature sterilization of stents
|
US20080014244A1
(en)
*
|
2006-07-13 |
2008-01-17 |
Gale David C |
Implantable medical devices and coatings therefor comprising physically crosslinked block copolymers
|
US7794495B2
(en)
*
|
2006-07-17 |
2010-09-14 |
Advanced Cardiovascular Systems, Inc. |
Controlled degradation of stents
|
US7886419B2
(en)
*
|
2006-07-18 |
2011-02-15 |
Advanced Cardiovascular Systems, Inc. |
Stent crimping apparatus and method
|
US8016879B2
(en)
*
|
2006-08-01 |
2011-09-13 |
Abbott Cardiovascular Systems Inc. |
Drug delivery after biodegradation of the stent scaffolding
|
US20080091262A1
(en)
*
|
2006-10-17 |
2008-04-17 |
Gale David C |
Drug delivery after biodegradation of the stent scaffolding
|
US9173733B1
(en)
|
2006-08-21 |
2015-11-03 |
Abbott Cardiovascular Systems Inc. |
Tracheobronchial implantable medical device and methods of use
|
US7923022B2
(en)
*
|
2006-09-13 |
2011-04-12 |
Advanced Cardiovascular Systems, Inc. |
Degradable polymeric implantable medical devices with continuous phase and discrete phase
|
WO2008147426A2
(en)
*
|
2006-10-04 |
2008-12-04 |
The Brigham And Women's Hospital, Inc. |
Methods and compositions for immunomodulation
|
US20080112961A1
(en)
*
|
2006-10-09 |
2008-05-15 |
Macrogenics, Inc. |
Identification and Engineering of Antibodies with Variant Fc Regions and Methods of Using Same
|
US7645616B2
(en)
*
|
2006-10-20 |
2010-01-12 |
The University Of Hong Kong |
Use of lipocalin-2 as a diagnostic marker and therapeutic target
|
US8337883B2
(en)
|
2006-11-03 |
2012-12-25 |
Durect Corporation |
Transdermal delivery systems
|
US9492596B2
(en)
*
|
2006-11-06 |
2016-11-15 |
Atrium Medical Corporation |
Barrier layer with underlying medical device and one or more reinforcing support structures
|
US7718649B1
(en)
*
|
2006-11-10 |
2010-05-18 |
Pisgah Labs, Inc. |
Physical states of a pharmaceutical drug substance
|
EP2092941A3
(en)
*
|
2006-11-20 |
2009-11-18 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US20080175887A1
(en)
|
2006-11-20 |
2008-07-24 |
Lixiao Wang |
Treatment of Asthma and Chronic Obstructive Pulmonary Disease With Anti-proliferate and Anti-inflammatory Drugs
|
US8425459B2
(en)
|
2006-11-20 |
2013-04-23 |
Lutonix, Inc. |
Medical device rapid drug releasing coatings comprising a therapeutic agent and a contrast agent
|
US20080276935A1
(en)
|
2006-11-20 |
2008-11-13 |
Lixiao Wang |
Treatment of asthma and chronic obstructive pulmonary disease with anti-proliferate and anti-inflammatory drugs
|
US9700704B2
(en)
|
2006-11-20 |
2017-07-11 |
Lutonix, Inc. |
Drug releasing coatings for balloon catheters
|
US9737640B2
(en)
|
2006-11-20 |
2017-08-22 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US8414526B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Medical device rapid drug releasing coatings comprising oils, fatty acids, and/or lipids
|
US8414910B2
(en)
|
2006-11-20 |
2013-04-09 |
Lutonix, Inc. |
Drug releasing coatings for medical devices
|
US8652466B2
(en)
*
|
2006-12-08 |
2014-02-18 |
Macrogenics, Inc. |
Methods for the treatment of disease using immunoglobulins having Fc regions with altered affinities for FcγRactivating and FcγRinhibiting
|
US8099849B2
(en)
|
2006-12-13 |
2012-01-24 |
Abbott Cardiovascular Systems Inc. |
Optimizing fracture toughness of polymeric stent
|
WO2008077145A2
(en)
|
2006-12-20 |
2008-06-26 |
Xoma Technology Ltd. |
Treatment of il-1-beta related diseases
|
US20090112197A1
(en)
|
2007-10-30 |
2009-04-30 |
Searete Llc |
Devices configured to facilitate release of nitric oxide
|
US20110190604A1
(en)
*
|
2006-12-22 |
2011-08-04 |
Hyde Roderick A |
Nitric oxide sensors and systems
|
US8642093B2
(en)
*
|
2007-10-30 |
2014-02-04 |
The Invention Science Fund I, Llc |
Methods and systems for use of photolyzable nitric oxide donors
|
US7862598B2
(en)
*
|
2007-10-30 |
2011-01-04 |
The Invention Science Fund I, Llc |
Devices and systems that deliver nitric oxide
|
US8221690B2
(en)
*
|
2007-10-30 |
2012-07-17 |
The Invention Science Fund I, Llc |
Systems and devices that utilize photolyzable nitric oxide donors
|
WO2008086529A2
(en)
*
|
2007-01-11 |
2008-07-17 |
Yale University |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
DK2148691T3
(en)
|
2007-02-05 |
2015-08-17 |
Apellis Pharmaceuticals Inc |
Compstatinanaloger for use in the treatment of inflammatory states of the respiratory system
|
PT2115029E
(en)
|
2007-02-15 |
2015-10-26 |
Tolmar Therapeutics Inc |
Low burst poly-(lactide/glycolide) and methods to produce polymers
|
WO2008116216A1
(en)
*
|
2007-03-22 |
2008-09-25 |
Medical College Of Georgia Research Institute, Inc. |
Compositions and methods for inhibiting cancer metastasis
|
US20080243228A1
(en)
*
|
2007-03-28 |
2008-10-02 |
Yunbing Wang |
Implantable medical devices fabricated from block copolymers
|
US8262723B2
(en)
|
2007-04-09 |
2012-09-11 |
Abbott Cardiovascular Systems Inc. |
Implantable medical devices fabricated from polymer blends with star-block copolymers
|
SI2644205T1
(en)
|
2007-04-12 |
2018-11-30 |
The Brigham And Women's Hospital, Inc. |
Targeting ABCB5 for cancer therapy
|
US20100179158A1
(en)
*
|
2007-04-20 |
2010-07-15 |
Hoffman Charles S |
Inhibitors of cyclic amp phosphodiesterases
|
EP2152304B1
(en)
|
2007-05-02 |
2018-08-22 |
The Regents of the University of Michigan |
Nanoemulsion therapeutic compositions and methods of using the same
|
US20100285041A1
(en)
*
|
2007-05-17 |
2010-11-11 |
Eugen Uhlmann |
Class A Oligonucleotides with Immunostimulatory Potency
|
MX337286B
(en)
|
2007-05-25 |
2016-02-22 |
Indivior Uk Ltd |
Sustained delivery formulations of risperidone compounds.
|
US7829008B2
(en)
*
|
2007-05-30 |
2010-11-09 |
Abbott Cardiovascular Systems Inc. |
Fabricating a stent from a blow molded tube
|
US7959857B2
(en)
*
|
2007-06-01 |
2011-06-14 |
Abbott Cardiovascular Systems Inc. |
Radiation sterilization of medical devices
|
US20080306582A1
(en)
*
|
2007-06-05 |
2008-12-11 |
Yunbing Wang |
Implantable medical devices with elastomeric copolymer coatings
|
US8202528B2
(en)
*
|
2007-06-05 |
2012-06-19 |
Abbott Cardiovascular Systems Inc. |
Implantable medical devices with elastomeric block copolymer coatings
|
US8293260B2
(en)
*
|
2007-06-05 |
2012-10-23 |
Abbott Cardiovascular Systems Inc. |
Elastomeric copolymer coatings containing poly (tetramethyl carbonate) for implantable medical devices
|
US8425591B1
(en)
|
2007-06-11 |
2013-04-23 |
Abbott Cardiovascular Systems Inc. |
Methods of forming polymer-bioceramic composite medical devices with bioceramic particles
|
US8524444B2
(en)
*
|
2007-06-15 |
2013-09-03 |
President And Fellows Of Harvard College |
Methods and compositions for detections and modulating O-glycosylation
|
EP2158221B1
(en)
|
2007-06-21 |
2018-08-29 |
MacroGenics, Inc. |
Covalent diabodies and uses thereof
|
AU2008265600B2
(en)
|
2007-06-21 |
2013-10-31 |
Neuronascent, Inc. |
Methods and compositions for stimulating neurogenesis and inhibiting neuronal degeneration using isothiazolopyrimidinones
|
WO2009002456A2
(en)
*
|
2007-06-21 |
2008-12-31 |
Massachusetts Institute Of Technology |
Methods and compositions relating to progenitor cells
|
US8048441B2
(en)
|
2007-06-25 |
2011-11-01 |
Abbott Cardiovascular Systems, Inc. |
Nanobead releasing medical devices
|
US7901452B2
(en)
*
|
2007-06-27 |
2011-03-08 |
Abbott Cardiovascular Systems Inc. |
Method to fabricate a stent having selected morphology to reduce restenosis
|
US7955381B1
(en)
|
2007-06-29 |
2011-06-07 |
Advanced Cardiovascular Systems, Inc. |
Polymer-bioceramic composite implantable medical device with different types of bioceramic particles
|
WO2009022215A1
(en)
|
2007-08-13 |
2009-02-19 |
Pfizer Inc. |
Combination motif immune stimulatory oligonucleotides with improved activity
|
US7897399B2
(en)
|
2007-10-30 |
2011-03-01 |
The Invention Science Fund I, Llc |
Nitric oxide sensors and systems
|
US10080823B2
(en)
|
2007-10-30 |
2018-09-25 |
Gearbox Llc |
Substrates for nitric oxide releasing devices
|
US20090112055A1
(en)
*
|
2007-10-30 |
2009-04-30 |
Searete Llc, A Limited Liability Corporation Of The State Of Delaware |
Sleeves configured to facilitate release of nitric oxide
|
US7846400B2
(en)
*
|
2007-10-30 |
2010-12-07 |
The Invention Science Fund I, Llc |
Substrates for nitric oxide releasing devices
|
US8980332B2
(en)
|
2007-10-30 |
2015-03-17 |
The Invention Science Fund I, Llc |
Methods and systems for use of photolyzable nitric oxide donors
|
US8877508B2
(en)
*
|
2007-10-30 |
2014-11-04 |
The Invention Science Fund I, Llc |
Devices and systems that deliver nitric oxide
|
KR20100067684A
(en)
*
|
2007-11-05 |
2010-06-21 |
보오슈 앤드 롬 인코포레이팃드 |
Water-immiscible materials as vehicles for drug delivery
|
CA2706658A1
(en)
|
2007-12-06 |
2009-06-18 |
Durect Corporation |
Methods useful for the treatment of pain, arthritic conditions or inflammation associated with a chronic condition
|
PL2391650T3
(en)
|
2007-12-20 |
2015-03-31 |
Xoma Us Llc |
Methods for the treatment of gout
|
US20090181068A1
(en)
*
|
2008-01-14 |
2009-07-16 |
Dunn Richard L |
Low Viscosity Liquid Polymeric Delivery System
|
WO2009111375A2
(en)
*
|
2008-03-01 |
2009-09-11 |
Abraxis Bioscience, Llc |
Treatment, diagnostic, and method for discovering antagonist using sparc specific mirnas
|
WO2009113989A1
(en)
|
2008-03-14 |
2009-09-17 |
Bionumerik Pharmaceuticals, Inc. |
Compositions and methods of use of compounds to increase cancer patient survival time
|
US8685995B2
(en)
*
|
2008-03-21 |
2014-04-01 |
The University Of Chicago |
Treatment with opioid antagonists and mTOR inhibitors
|
BRPI0906309A2
(en)
*
|
2008-04-02 |
2020-05-26 |
Macrogenics, Inc |
IMMUNOGLOBULIN, ANTIBODY, USE OF ANTIBODY AND PHARMACEUTICAL COMPOSITION
|
ES2654937T3
(en)
|
2008-04-02 |
2018-02-15 |
Macrogenics, Inc. |
Specific antibodies for the BCR complex and procedures for their use
|
EP2385370A1
(en)
|
2008-04-10 |
2011-11-09 |
Massachusetts Institute of Technology (MIT) |
Methods for identification and use of agents targeting cancer stem cells
|
US20100227853A1
(en)
*
|
2008-04-18 |
2010-09-09 |
Trustees Of Boston College |
Inhibitors of cyclic amp phosphodiesterases
|
US20110076296A1
(en)
|
2008-04-25 |
2011-03-31 |
Innate Pharma S.A. |
TLR3 Agonist Compositions
|
CN102076853A
(en)
*
|
2008-05-07 |
2011-05-25 |
阿布拉西斯生物科学有限责任公司 |
Enhancement of drug therapy by mirna
|
US9486531B2
(en)
*
|
2008-06-03 |
2016-11-08 |
Indivior Uk Limited |
Dehydrated hydrogel inclusion complex of a bioactive agent with flowable drug delivery system
|
CA2726763A1
(en)
*
|
2008-06-03 |
2009-12-10 |
Tolmar Therapeutics, Inc. |
Controlled release copolymer formulation with improved release kinetics
|
WO2010033279A2
(en)
*
|
2008-06-04 |
2010-03-25 |
Macrogenics, Inc. |
Antibodies with altered binding to fcrn and methods of using same
|
EP2303888B1
(en)
|
2008-06-12 |
2015-05-06 |
President and Fellows of Harvard College |
Compounds for antimicrobial intervention
|
EP2326304A2
(en)
|
2008-07-17 |
2011-06-01 |
Merial Limited |
Methods for enhancing the stability of polyorthoesters and their formulations
|
CA2737146A1
(en)
|
2008-07-25 |
2010-01-28 |
The Regents Of The University Of Colorado |
Clip inhibitors and methods of modulating immune function
|
US8614189B2
(en)
*
|
2008-09-24 |
2013-12-24 |
University Of Connecticut |
Carbon nanotube composite scaffolds for bone tissue engineering
|
EP2349209A2
(en)
*
|
2008-09-26 |
2011-08-03 |
Nanobio Corporation |
Nanoemulsion therapeutic compositions and methods of using the same
|
US9554826B2
(en)
|
2008-10-03 |
2017-01-31 |
Femasys, Inc. |
Contrast agent injection system for sonographic imaging
|
US10070888B2
(en)
|
2008-10-03 |
2018-09-11 |
Femasys, Inc. |
Methods and devices for sonographic imaging
|
KR20110069144A
(en)
|
2008-10-09 |
2011-06-22 |
미네르바 바이오테크놀로지 코포레이션 |
Method for inducing pluripotency in cells
|
US20100260844A1
(en)
|
2008-11-03 |
2010-10-14 |
Scicinski Jan J |
Oral pharmaceutical dosage forms
|
EP3734281A3
(en)
|
2008-11-14 |
2021-01-27 |
The Brigham and Women's Hospital, Inc. |
Therapeutic and diagnostic methods relating to cancer stem cells
|
CA2743904A1
(en)
|
2008-11-17 |
2010-05-20 |
The Regents Of The University Of Michigan |
Cancer vaccine compositions and methods of using the same
|
KR101940059B1
(en)
|
2008-12-19 |
2019-01-18 |
마크로제닉스, 인크. |
Covalent diabodies and uses thereof
|
US20100260677A1
(en)
|
2009-03-02 |
2010-10-14 |
Massachusetts Institute Of Technology |
Methods and systems for treatment and/or diagnosis
|
US8309356B2
(en)
*
|
2009-04-01 |
2012-11-13 |
Yale University |
Pseudocomplementary oligonucleotides for targeted gene therapy
|
SI2992899T1
(en)
|
2009-05-14 |
2020-10-30 |
Bayer Intellectual Property Gmbh |
Enhanced immune response in avian species
|
JP2012528858A
(en)
|
2009-06-01 |
2012-11-15 |
プレジデント アンド フェロウズ オブ ハーバード カレッジ |
O-GlcNAc transferase inhibitor and use thereof
|
US20100310623A1
(en)
*
|
2009-06-05 |
2010-12-09 |
Laurencin Cato T |
Synergetic functionalized spiral-in-tubular bone scaffolds
|
US20100316673A1
(en)
|
2009-06-16 |
2010-12-16 |
The Regents Of The University Of Michigan |
Nanoemulsion vaccines
|
WO2010151682A2
(en)
*
|
2009-06-25 |
2010-12-29 |
Rochester Medical Corporation |
Silicone catheter containing chlorhexidine gluconate
|
WO2011011092A1
(en)
|
2009-07-22 |
2011-01-27 |
University Of Massachusetts |
Methods and compositions to reduce oxidative stress
|
KR20120107456A
(en)
|
2009-07-30 |
2012-10-02 |
안티센스 파마 게엠베하 |
Combination of a chemotherapeutic agent and an inhibitor of the tgf-beta system
|
US20110038910A1
(en)
|
2009-08-11 |
2011-02-17 |
Atrium Medical Corporation |
Anti-infective antimicrobial-containing biomaterials
|
EP2287304A1
(en)
|
2009-08-17 |
2011-02-23 |
Max-Planck-Gesellschaft zur Förderung der Wissenschaften e.V. |
Novel treatment of patients after stent implantation or balloon dilatation and novel drug eluting stents
|
CN105669553A
(en)
|
2009-08-18 |
2016-06-15 |
文蒂雷克斯药品公司 |
Substituted benzoazepines as Toll-like receptor modulators
|
EP2467380B1
(en)
|
2009-08-18 |
2016-11-30 |
Ventirx Pharmaceuticals, Inc. |
Substituted benzoazepines as toll-like receptor modulators
|
LT2486141T
(en)
|
2009-10-07 |
2018-05-25 |
Macrogenics, Inc. |
Fc region-containing polypeptides that exhibit improved effector function due to alterations of the extent of fucosylation, and methods for their use
|
US8808353B2
(en)
|
2010-01-30 |
2014-08-19 |
Abbott Cardiovascular Systems Inc. |
Crush recoverable polymer scaffolds having a low crossing profile
|
US8568471B2
(en)
|
2010-01-30 |
2013-10-29 |
Abbott Cardiovascular Systems Inc. |
Crush recoverable polymer scaffolds
|
SG10201604336VA
(en)
|
2010-03-04 |
2016-07-28 |
Macrogenics Inc |
Antibodies Reactive With B7-H3, Immunologically Active Fragments Thereof And Uses Thereof
|
US8802091B2
(en)
|
2010-03-04 |
2014-08-12 |
Macrogenics, Inc. |
Antibodies reactive with B7-H3 and uses thereof
|
DE102010014113A1
(en)
*
|
2010-04-07 |
2011-10-13 |
Acino Ag |
Release procedure for implants
|
US20110293585A1
(en)
|
2010-04-21 |
2011-12-01 |
Helix Therapeutics, Inc. |
Compositions and methods for treatment of lysosomal storage disorders
|
WO2011133803A1
(en)
|
2010-04-21 |
2011-10-27 |
Helix Therapeutics, Inc. |
Compositions and methods for targeted inactivation of hiv cell surface receptors
|
KR20130107203A
(en)
|
2010-05-04 |
2013-10-01 |
더 브리검 앤드 우먼즈 하스피털, 인크. |
Detection and treatment of fibrosis
|
WO2011143187A2
(en)
|
2010-05-10 |
2011-11-17 |
University Of Connecticut |
Lactoferrin -based biomaterials for tissue regeneration and drug delivery
|
CA2794841C
(en)
|
2010-05-20 |
2021-02-23 |
Ecolab Usa Inc. |
Rheology modified low foaming liquid antimicrobial compositions and methods of use thereof
|
US9272044B2
(en)
|
2010-06-08 |
2016-03-01 |
Indivior Uk Limited |
Injectable flowable composition buprenorphine
|
GB2513060B
(en)
|
2010-06-08 |
2015-01-07 |
Rb Pharmaceuticals Ltd |
Microparticle buprenorphine suspension
|
US8658603B2
(en)
|
2010-06-16 |
2014-02-25 |
The Regents Of The University Of Michigan |
Compositions and methods for inducing an immune response
|
WO2012009707A2
(en)
|
2010-07-16 |
2012-01-19 |
Atrium Medical Corporation |
Composition and methods for altering the rate of hydrolysis of cured oil-based materials
|
SG187682A1
(en)
|
2010-08-02 |
2013-03-28 |
Macrogenics Inc |
Covalent diabodies and uses thereof
|
NZ612285A
(en)
|
2010-12-22 |
2015-09-25 |
Bayer Ip Gmbh |
Enhanced immune response in bovine species
|
WO2012092539A2
(en)
|
2010-12-31 |
2012-07-05 |
Takeda Pharmaceutical Company Limited |
Antibodies to dll4 and uses thereof
|
CN106749023A
(en)
|
2011-01-12 |
2017-05-31 |
帆德制药股份有限公司 |
As the substituted benzazepine of toll-like receptor conditioning agent
|
EP3207930A1
(en)
|
2011-01-12 |
2017-08-23 |
VentiRx Pharmaceuticals, Inc. |
Substituted benzoazepines as toll-like receptor modulators
|
MY165507A
(en)
|
2011-02-03 |
2018-03-28 |
Mirna Therapeutics Inc |
Synthetic mimics of mir-34
|
EP2670849A1
(en)
|
2011-02-03 |
2013-12-11 |
Mirna Therapeutics, Inc. |
Synthetic mimics of mir-124
|
US9707375B2
(en)
|
2011-03-14 |
2017-07-18 |
Rochester Medical Corporation, a subsidiary of C. R. Bard, Inc. |
Catheter grip and method
|
EP2699264B1
(en)
|
2011-04-20 |
2018-03-14 |
Medlmmune, LLC |
Antibodies and other molecules that bind b7-h1 and pd-1
|
CN105148285B
(en)
|
2011-04-21 |
2019-02-12 |
塔夫茨大学信托人 |
For the stabilized method and composition of active agent
|
US9376495B2
(en)
|
2011-05-21 |
2016-06-28 |
Macrogenics, Inc. |
Deimmunized serum-binding domains and their use in extending serum half-life
|
CA2837227C
(en)
|
2011-06-01 |
2022-05-10 |
Janus Biotherapeutics, Inc. |
Novel immune system modulators
|
US9353115B2
(en)
|
2011-06-01 |
2016-05-31 |
Janus Biotherapeutics, Inc. |
Immune system modulators
|
CA2842321C
(en)
|
2011-07-18 |
2022-05-03 |
President And Fellows Of Harvard College |
Engineered microbe-targeting molecules and uses thereof
|
WO2013013061A1
(en)
|
2011-07-19 |
2013-01-24 |
University Of Vermont And State Agricultural College |
Methods and compounds for treating cancer
|
US8726483B2
(en)
|
2011-07-29 |
2014-05-20 |
Abbott Cardiovascular Systems Inc. |
Methods for uniform crimping and deployment of a polymer scaffold
|
WO2013020044A1
(en)
|
2011-08-03 |
2013-02-07 |
The Charlotte-Mecklenburg Hospital Authority D/B/A Carolinas Medical Center |
Treatment of fibrosis using microrna-19b
|
AU2012296613B2
(en)
|
2011-08-15 |
2016-05-12 |
Amplimmune, Inc. |
Anti-B7-H4 antibodies and their uses
|
SG10201601086WA
(en)
|
2011-08-18 |
2016-03-30 |
Otago Innovation Ltd |
Cardiovascular therapeutics
|
KR101494594B1
(en)
|
2011-08-30 |
2015-02-23 |
주식회사 종근당 |
Sustained-release lipid pre-concentrate of pharmacologically active substance and pharmaceutical composition comprising the same
|
AU2012318694B2
(en)
|
2011-10-04 |
2016-12-22 |
Janus Biotherapeutics, Inc. |
Novel imidazole quinoline-based immune system modulators
|
CA2856520C
(en)
|
2011-11-23 |
2021-04-06 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US9301920B2
(en)
|
2012-06-18 |
2016-04-05 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US9173884B2
(en)
|
2011-11-30 |
2015-11-03 |
Trustees Of Boston College |
Inhibitors of phosphodiesterase 11 (PDE11)
|
EP2794657B1
(en)
|
2011-12-19 |
2017-10-11 |
Xoma (Us) Llc |
Methods for treating acne
|
US20130158132A1
(en)
*
|
2011-12-19 |
2013-06-20 |
Aida Salatinjants |
Formulation Solution Adapted To Prolong Plasma Times Of Drugs In Mammals Including Humans
|
AU2013208007A1
(en)
|
2012-01-09 |
2014-07-31 |
The Scripps Research Institute |
Humanized antibodies with ultralong CDR3
|
JP6684490B2
(en)
|
2012-01-09 |
2020-04-22 |
ザ・スクリップス・リサーチ・インスティテュート |
Ultralong complementarity determining regions and uses thereof
|
US9867880B2
(en)
|
2012-06-13 |
2018-01-16 |
Atrium Medical Corporation |
Cured oil-hydrogel biomaterial compositions for controlled drug delivery
|
US20150196640A1
(en)
|
2012-06-18 |
2015-07-16 |
Therapeuticsmd, Inc. |
Progesterone formulations having a desirable pk profile
|
US10806697B2
(en)
|
2012-12-21 |
2020-10-20 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10806740B2
(en)
|
2012-06-18 |
2020-10-20 |
Therapeuticsmd, Inc. |
Natural combination hormone replacement formulations and therapies
|
US20130338122A1
(en)
|
2012-06-18 |
2013-12-19 |
Therapeuticsmd, Inc. |
Transdermal hormone replacement therapies
|
CN110812470A
(en)
|
2012-07-11 |
2020-02-21 |
佛蒙特大学及州农业学院 |
Methods and compositions for metabolic regulation
|
CN104684923B
(en)
|
2012-07-13 |
2018-09-28 |
株式会社新日本科学 |
Chiral Nuclec acid adjuvants
|
EP3795694A3
(en)
|
2012-10-02 |
2021-06-23 |
The General Hospital Corporation d/b/a Massachusetts General Hospital |
Methods relating to dna-sensing pathway related conditions
|
WO2014055941A2
(en)
|
2012-10-04 |
2014-04-10 |
Pappalardo Juan Sabastian |
Compounds and methods for targeted immune system delivery
|
WO2014074805A1
(en)
|
2012-11-08 |
2014-05-15 |
Whitehead Institute For Biomedical Research |
Selective targeting of cancer stem cells
|
US9872969B2
(en)
|
2012-11-20 |
2018-01-23 |
Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. |
Catheter in bag without additional packaging
|
US10092728B2
(en)
|
2012-11-20 |
2018-10-09 |
Rochester Medical Corporation, a subsidiary of C.R. Bard, Inc. |
Sheath for securing urinary catheter
|
US9750718B2
(en)
|
2012-12-12 |
2017-09-05 |
The Charlotte-Mecklenburg Hospital Authority |
Methods of treating hepatic fibrosis and associated diseases by regulating Rev-ERB activity
|
US9872851B2
(en)
|
2012-12-12 |
2018-01-23 |
The Charlotte-Mecklenburg Hospital Authority |
Methods of treating portal hypertension
|
CA2894879A1
(en)
|
2012-12-19 |
2014-06-26 |
Amplimmune, Inc. |
B7-h4 specific antibodies, and compositions and methods of use thereof
|
US10568891B2
(en)
|
2012-12-21 |
2020-02-25 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US9180091B2
(en)
|
2012-12-21 |
2015-11-10 |
Therapeuticsmd, Inc. |
Soluble estradiol capsule for vaginal insertion
|
US11246875B2
(en)
|
2012-12-21 |
2022-02-15 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US11266661B2
(en)
|
2012-12-21 |
2022-03-08 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10537581B2
(en)
|
2012-12-21 |
2020-01-21 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
US10471072B2
(en)
|
2012-12-21 |
2019-11-12 |
Therapeuticsmd, Inc. |
Vaginal inserted estradiol pharmaceutical compositions and methods
|
CA2896091C
(en)
|
2012-12-21 |
2018-06-19 |
Amplimmune, Inc. |
Anti-h7cr antibodies
|
KR101586789B1
(en)
|
2012-12-28 |
2016-01-19 |
주식회사 종근당 |
Sustained-release lipid pre-concentrate of cationic pharmacologically active substance and pharmaceutical composition comprising the same
|
KR101586791B1
(en)
|
2012-12-28 |
2016-01-19 |
주식회사 종근당 |
Sustained-release lipid pre-concentrate of GnRH analogues and pharmaceutical composition comprising the same
|
KR101586790B1
(en)
|
2012-12-28 |
2016-01-19 |
주식회사 종근당 |
Sustained-release lipid pre-concentrate of anionic pharmacologically active substances and pharmaceutical composition comprising the same
|
US9487587B2
(en)
|
2013-03-05 |
2016-11-08 |
Macrogenics, Inc. |
Bispecific molecules that are immunoreactive with immune effector cells of a companion animal that express an activating receptor and cells that express B7-H3 and uses thereof
|
CN105377355A
(en)
|
2013-03-14 |
2016-03-02 |
拇趾公司 |
Method of treating infections, diseases or disorders of nail unit
|
US11376329B2
(en)
|
2013-03-15 |
2022-07-05 |
Trustees Of Tufts College |
Low molecular weight silk compositions and stabilizing silk compositions
|
JP6457482B2
(en)
|
2013-03-15 |
2019-01-23 |
トラスティーズ オブ タフツ カレッジ |
Low molecular weight silk composition and stabilization of silk composition
|
CN105120659A
(en)
|
2013-03-15 |
2015-12-02 |
度瑞公司 |
Compositions with a rheological modifier to reduce dissolution variability
|
CA2913312A1
(en)
|
2013-05-24 |
2014-11-27 |
Medimmune, Llc |
Anti-b7-h5 antibodies and their uses
|
WO2015010100A2
(en)
|
2013-07-18 |
2015-01-22 |
Fabrus, Inc. |
Humanized antibodies with ultralong complementarity determining regions
|
WO2015017146A2
(en)
|
2013-07-18 |
2015-02-05 |
Fabrus, Inc. |
Antibodies with ultralong complementarity determining regions
|
UA116479C2
(en)
|
2013-08-09 |
2018-03-26 |
Макродженікс, Інк. |
Bi-specific monovalent fc diabodies that are capable of binding cd32b and cd79b and uses thereof
|
EP2839842A1
(en)
|
2013-08-23 |
2015-02-25 |
MacroGenics, Inc. |
Bi-specific monovalent diabodies that are capable of binding CD123 and CD3 and uses thereof
|
EP2840091A1
(en)
|
2013-08-23 |
2015-02-25 |
MacroGenics, Inc. |
Bi-specific diabodies that are capable of binding gpA33 and CD3 and uses thereof
|
EP3043824B1
(en)
|
2013-09-13 |
2022-07-06 |
The Scripps Research Institute |
Modified therapeutic agents and compositions thereof
|
AU2014337385B2
(en)
|
2013-10-15 |
2020-04-30 |
The Scripps Research Institute |
Chimeric antigen receptor T cell switches and uses thereof
|
EP3057994B1
(en)
|
2013-10-15 |
2020-09-23 |
The Scripps Research Institute |
Peptidic chimeric antigen receptor t cell switches and uses thereof
|
EP3063171B1
(en)
|
2013-11-01 |
2019-07-24 |
University Of Oslo |
Albumin variants and uses thereof
|
US11452767B2
(en)
|
2013-11-15 |
2022-09-27 |
Oslo Universitetssykehus Hf |
CTL peptide epitopes and antigen-specific t cells, methods for their discovery, and uses thereof
|
US10801070B2
(en)
|
2013-11-25 |
2020-10-13 |
The Broad Institute, Inc. |
Compositions and methods for diagnosing, evaluating and treating cancer
|
US11725237B2
(en)
|
2013-12-05 |
2023-08-15 |
The Broad Institute Inc. |
Polymorphic gene typing and somatic change detection using sequencing data
|
US20160303242A1
(en)
|
2013-12-09 |
2016-10-20 |
Durect Corporation |
Pharmaceutically Active Agent Complexes, Polymer Complexes, and Compositions and Methods Involving the Same
|
EP3082797A4
(en)
|
2013-12-18 |
2017-12-13 |
The California Institute for Biomedical Research |
Modified therapeutic agents, stapled peptide lipid conjugates, and compositions thereof
|
EP3083658B1
(en)
|
2013-12-18 |
2019-05-08 |
President and Fellows of Harvard College |
Crp capture/detection of gram positive bacteria
|
CN106456724A
(en)
|
2013-12-20 |
2017-02-22 |
博德研究所 |
Combination therapy with neoantigen vaccine
|
JPWO2015108048A1
(en)
|
2014-01-15 |
2017-03-23 |
株式会社新日本科学 |
Chiral nucleic acid adjuvant and antitumor agent having antitumor activity
|
JPWO2015108047A1
(en)
|
2014-01-15 |
2017-03-23 |
株式会社新日本科学 |
Chiral nucleic acid adjuvant having immunity induction activity and immunity induction activator
|
EP3095460A4
(en)
|
2014-01-15 |
2017-08-23 |
Shin Nippon Biomedical Laboratories, Ltd. |
Chiral nucleic acid adjuvant having anti-allergic activity, and anti-allergic agent
|
SG11201606714TA
(en)
|
2014-02-14 |
2016-09-29 |
Andrew S Chi |
Improved methods for the treatment of vascularizing cancers
|
WO2015128461A1
(en)
|
2014-02-28 |
2015-09-03 |
Bayer Animal Health Gmbh |
Immunostimulatory plasmids
|
GB201404139D0
(en)
|
2014-03-10 |
2014-04-23 |
Rb Pharmaceuticals Ltd |
Sustained release buprenorphine solution formulations
|
WO2015168255A1
(en)
|
2014-04-29 |
2015-11-05 |
Whitehead Institute For Biomedical Research |
Methods and compositions for targeting cancer stem cells
|
PL3140269T3
(en)
|
2014-05-09 |
2024-03-11 |
Yale University |
Hyperbranched polyglycerol-coated particles and methods of making and using thereof
|
US11918695B2
(en)
|
2014-05-09 |
2024-03-05 |
Yale University |
Topical formulation of hyperbranched polymer-coated particles
|
MX2016014281A
(en)
|
2014-05-22 |
2017-02-22 |
Therapeuticsmd Inc |
Natural combination hormone replacement formulations and therapies.
|
NZ726520A
(en)
|
2014-05-29 |
2018-12-21 |
Macrogenics Inc |
Tri-specific binding molecules that specifically bind to multiple cancer antigens and methods of use thereof
|
TWI693232B
(en)
|
2014-06-26 |
2020-05-11 |
美商宏觀基因股份有限公司 |
Covalently bonded diabodies having immunoreactivity with pd-1 and lag-3, and methods of use thereof
|
EP3398948A3
(en)
|
2014-08-22 |
2018-12-05 |
Janus Biotherapeutics, Inc. |
2,4,6,7-tetrasubstituted pteridine compounds and methods of synthesis and use thereof
|
WO2016033234A1
(en)
|
2014-08-26 |
2016-03-03 |
C.R. Bard, Inc |
Urinary catheter
|
US10633443B2
(en)
|
2014-09-26 |
2020-04-28 |
Macrogenics, Inc. |
Bi-specific monovalent diabodies that are capable of binding CD19 and CD3, and uses thereof
|
EP3204039B1
(en)
|
2014-10-10 |
2022-06-08 |
The Regents Of The University Of Michigan |
Nanoemulsion compositions for preventing, suppressing or eliminating allergic and inflammatory disease
|
US20160106804A1
(en)
|
2014-10-15 |
2016-04-21 |
Yuhua Li |
Pharmaceutical composition with improved stability
|
CA3002137A1
(en)
|
2014-10-17 |
2016-04-21 |
Salix Pharmaceuticals, Inc. |
Use of methylnaltrexone to attenuate tumor progression
|
EP3234193B1
(en)
|
2014-12-19 |
2020-07-15 |
Massachusetts Institute of Technology |
Molecular biomarkers for cancer immunotherapy
|
WO2016100977A1
(en)
|
2014-12-19 |
2016-06-23 |
The Broad Institute Inc. |
Methods for profiling the t-cel- receptor repertoire
|
WO2016130726A1
(en)
|
2015-02-10 |
2016-08-18 |
Minerva Biotechnologies Corporation |
Humanized anti-muc1* antibodies
|
US9999527B2
(en)
|
2015-02-11 |
2018-06-19 |
Abbott Cardiovascular Systems Inc. |
Scaffolds having radiopaque markers
|
CN107592866A
(en)
|
2015-02-18 |
2018-01-16 |
佛蒙特大学及州农业学院 |
MCJ activators and application thereof
|
CN107530416A
(en)
|
2015-03-05 |
2018-01-02 |
西北大学 |
Virus that non-nerve infects and application thereof
|
US10800828B2
(en)
|
2015-03-26 |
2020-10-13 |
The Scripps Research Institute |
Switchable non-scFv chimeric receptors, switches, and methods of use thereof to treat cancer
|
CA3019311A1
(en)
|
2015-04-15 |
2016-10-20 |
University Of Massachusetts |
Compositions and methods for xi chromosome reactivation
|
EP3283113A4
(en)
|
2015-04-15 |
2018-12-05 |
The California Institute for Biomedical Research |
Optimized pne-based chimeric receptor t cell switches and uses thereof
|
CR20230191A
(en)
|
2015-05-20 |
2023-07-06 |
Dana Farber Cancer Inst Inc |
SHARED NEOANTIGENS (Div. exp 2017-584)
|
TWI773646B
(en)
|
2015-06-08 |
2022-08-11 |
美商宏觀基因股份有限公司 |
Lag-3-binding molecules and methods of use thereof
|
US9700443B2
(en)
|
2015-06-12 |
2017-07-11 |
Abbott Cardiovascular Systems Inc. |
Methods for attaching a radiopaque marker to a scaffold
|
US20190000928A1
(en)
|
2015-06-17 |
2019-01-03 |
The California Institute For Biomedical Research |
Modified therapeutic agents and compositions thereof
|
JP2018521130A
(en)
|
2015-07-10 |
2018-08-02 |
ユニバーシティ・オブ・バーモント・アンド・ステイト・アグリカルチュラル・カレッジUniversity Of Vermont And State Agricultural College |
Methods and compositions for treating drug diseases and conditions
|
US10328087B2
(en)
|
2015-07-23 |
2019-06-25 |
Therapeuticsmd, Inc. |
Formulations for solubilizing hormones
|
EP3328419B1
(en)
|
2015-07-30 |
2021-08-25 |
MacroGenics, Inc. |
Pd-1-binding molecules and methods of use thereof
|
US10435457B2
(en)
|
2015-08-06 |
2019-10-08 |
President And Fellows Of Harvard College |
Microbe-binding molecules and uses thereof
|
US10457941B2
(en)
|
2015-08-20 |
2019-10-29 |
ASOCIACION CENTRO DE INVESTIGACION COOPERATIVA EN BIOCIENCIAS-CIC bioGUNE |
Methods and compositions to treat liver diseases and conditions
|
CA2998745A1
(en)
|
2015-09-17 |
2017-03-23 |
University Of Massachusetts |
Compositions and methods for modulating fmr1 expression
|
CN108925136B
(en)
|
2015-12-02 |
2022-02-01 |
斯特赛恩斯公司 |
Antibodies specific for glycosylated BTLA (B and T lymphocyte attenuating factor)
|
CN109415437B
(en)
|
2015-12-02 |
2022-02-01 |
斯特库伯株式会社 |
Antibodies and molecules that immunospecifically bind to BTN1A1 and therapeutic uses thereof
|
CR20180318A
(en)
|
2015-12-14 |
2018-09-19 |
Macrogenics Inc |
BISPECIFIC MOLECULES THAT HAVE IMMUNORREACTIVITY WITH PD-1 AND CTLA-4, AND METHODS OF USE OF THE SAME
|
US20200308590A1
(en)
|
2016-02-16 |
2020-10-01 |
Yale University |
Compositions and methods for treatment of cystic fibrosis
|
US11136597B2
(en)
|
2016-02-16 |
2021-10-05 |
Yale University |
Compositions for enhancing targeted gene editing and methods of use thereof
|
WO2017173334A1
(en)
|
2016-04-01 |
2017-10-05 |
Checkmate Pharmaceuticals, Inc. |
Fc receptor-mediated drug delivery
|
WO2017173071A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical composition
|
WO2017173044A1
(en)
|
2016-04-01 |
2017-10-05 |
Therapeuticsmd Inc. |
Steroid hormone compositions in medium chain oils
|
CN109414489B
(en)
|
2016-04-08 |
2022-08-16 |
埃缇健康公司D/B/A泽尔拜尔 |
Netin-1 binding antibodies and uses thereof
|
CN109069633A
(en)
|
2016-04-15 |
2018-12-21 |
宏观基因有限公司 |
Novel B7-H3- binding molecule, its antibody drug conjugate and its application method
|
WO2017207623A1
(en)
|
2016-05-31 |
2017-12-07 |
Université de Lausanne |
Mirna as biomarkers and regulators of cancer stem cells
|
US20190322643A1
(en)
|
2016-06-29 |
2019-10-24 |
Georgia State University Research Foundation, Inc. |
Histone deacetylase and histone methyltransferase inhibitors and methods of making and use of the same
|
SG11201900710YA
(en)
|
2016-07-26 |
2019-02-27 |
Bayer Animal Health Gmbh |
Increased fertility in bovine species
|
US10188602B2
(en)
|
2016-09-29 |
2019-01-29 |
Gesea Biosciences Inc. |
Bioerodible implant for long-term drug delivery and associated methods of manufacture and use
|
CN110022794A
(en)
*
|
2016-10-05 |
2019-07-16 |
泰坦医药品公司 |
The implantable device for drug delivery of burst release with reduction
|
EP3529268A1
(en)
|
2016-10-19 |
2019-08-28 |
The Scripps Research Institute |
Chimeric antigen receptor effector cell switches with humanized targeting moieties and/or optimized chimeric antigen receptor interacting domains and uses thereof
|
EP3896451A1
(en)
|
2016-11-07 |
2021-10-20 |
University Of Massachusetts |
Carm1 inhibitors for facioscapulohumeral muscular dystrophy
|
WO2018096396A1
(en)
|
2016-11-22 |
2018-05-31 |
University Of Oslo |
Albumin variants and uses thereof
|
EP3574116A1
(en)
|
2017-01-24 |
2019-12-04 |
The Broad Institute, Inc. |
Compositions and methods for detecting a mutant variant of a polynucleotide
|
EP3576726A1
(en)
|
2017-02-06 |
2019-12-11 |
Massachusetts Institute Of Technology |
Methods and products related to glutaminase inhibitors
|
US20200113821A1
(en)
|
2017-04-04 |
2020-04-16 |
Yale University |
Compositions and methods for in utero delivery
|
US11225512B2
(en)
|
2017-04-27 |
2022-01-18 |
University Of New Hampshire |
Compositions and methods for ceramide-elevating therapeutic strategies
|
CN111051346A
(en)
|
2017-05-31 |
2020-04-21 |
斯特库伯株式会社 |
Methods of treating cancer using antibodies and molecules that immunospecifically bind to BTN1a1
|
CA3065301A1
(en)
|
2017-05-31 |
2018-12-06 |
Stcube & Co., Inc. |
Antibodies and molecules that immunospecifically bind to btn1a1 and the therapeutic uses thereof
|
US11542331B2
(en)
|
2017-06-06 |
2023-01-03 |
Stcube & Co., Inc. |
Methods of treating cancer using antibodies and molecules that bind to BTN1A1 or BTN1A1-ligands
|
WO2019014611A2
(en)
|
2017-07-14 |
2019-01-17 |
University Of Massachusetts |
Methods and compositions for treating inflammation
|
US20220118076A1
(en)
|
2017-09-07 |
2022-04-21 |
University Of Oslo |
Vaccine molecules
|
EP3678699A1
(en)
|
2017-09-07 |
2020-07-15 |
University Of Oslo |
Vaccine molecules
|
CA3070865A1
(en)
|
2017-09-19 |
2019-03-28 |
C.R. Bard, Inc. |
Urinary catheter bridging device, systems and methods thereof
|
US11717555B2
(en)
|
2017-12-18 |
2023-08-08 |
Foresee Pharmaceuticals Co., Ltd. |
Pharmaceutical compositions having a selected release duration
|
WO2019154884A1
(en)
|
2018-02-07 |
2019-08-15 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Method for determining cancer invasiveness and patient prognosis
|
PT3773537T
(en)
|
2018-04-19 |
2022-04-19 |
Baylor College Medicine |
Stat3 inhibitors
|
CN109289089B
(en)
*
|
2018-10-15 |
2021-12-28 |
福建师范大学 |
Preparation method of temperature-controlled intelligent drug release system based on titanium dioxide nanotube array
|
CN109289049B
(en)
*
|
2018-10-15 |
2021-04-02 |
福建师范大学 |
Preparation method of near-infrared light-controlled intelligent drug release system based on titanium dioxide nanotube array
|
EP3867365A1
(en)
|
2018-10-19 |
2021-08-25 |
Board of Regents, The University of Texas System |
Engineered long interspersed element (line) transposons and methods of use thereof
|
EP3883562A4
(en)
|
2018-11-21 |
2022-08-03 |
Tremeau Pharmaceuticals, Inc. |
Purified forms of rofecoxib, methods of manufacture and use
|
EP3677693A1
(en)
|
2019-01-03 |
2020-07-08 |
Ecole Polytechnique Federale De Lausanne (EPFL) EPFL-TTO |
Transpochimeric gene trancripts (tcgts) as cancer biomarkers
|
US20220175934A1
(en)
|
2019-03-21 |
2022-06-09 |
Mitotherapeutix Llc |
Multivalent ligand clusters for targeted delivery of therapeutic agents
|
WO2020257779A1
(en)
|
2019-06-21 |
2020-12-24 |
Yale University |
Hydroxymethyl-modified gamma-pna compositions and methods of use thereof
|
US20220243211A1
(en)
|
2019-06-21 |
2022-08-04 |
Yale University |
Peptide nucleic acid compositions with modified hoogsteen binding segments and methods of use thereof
|
WO2021022161A1
(en)
|
2019-07-31 |
2021-02-04 |
Yale University |
Compositions and methods for treating sickle cell disease
|
KR20220061977A
(en)
|
2019-08-12 |
2022-05-13 |
퓨리노미아 바이오테크, 아이엔씨. |
Methods and compositions for promoting and enhancing T cell mediated immune response through ADCC targeting of CD39 expressing cells
|
WO2021062323A1
(en)
|
2019-09-26 |
2021-04-01 |
Stcube & Co. |
Antibodies specific to glycosylated ctla-4 and methods of use thereof
|
JP2022552282A
(en)
|
2019-10-09 |
2022-12-15 |
エスティーキューブ アンド カンパニー |
Antibodies specific for glycosylated LAG3 and methods of use thereof
|
CN115551594A
(en)
|
2019-10-24 |
2022-12-30 |
米诺陶治疗公司 |
Cytokine-modified chimeric antibodies and methods of use thereof
|
US10945992B1
(en)
|
2019-11-13 |
2021-03-16 |
Tremeau Pharmaceuticals, Inc. |
Dosage forms of rofecoxib and related methods
|
CA3167217A1
(en)
|
2020-01-13 |
2021-07-22 |
Durect Corporation |
Sustained release drug delivery systems with reduced impurities and related methods
|
US11633405B2
(en)
|
2020-02-07 |
2023-04-25 |
Therapeuticsmd, Inc. |
Steroid hormone pharmaceutical formulations
|
EP4107267A1
(en)
|
2020-02-21 |
2022-12-28 |
Mitotherapeutix LLC |
Compositions and methods for inhibiting expression of methylation-controlled j-protein (mcj)
|
CA3180468A1
(en)
|
2020-06-30 |
2022-01-06 |
Jin Young Ko |
Injectable composition comprising gnrh analogue
|
US11161833B1
(en)
|
2021-04-09 |
2021-11-02 |
Tremeau Pharmaceuticals, Inc. |
Deuterated etoricoxib, methods of manufacture, and use thereof
|
WO2022232321A1
(en)
|
2021-04-28 |
2022-11-03 |
Minotaur Therapeutics, Inc. |
Humanized chimeric bovine antibodies and methods of use
|
WO2022237974A1
(en)
|
2021-05-12 |
2022-11-17 |
Ecole Polytechnique Federale De Lausanne (Epfl) |
Krab-containing zinc finger protein and cancer
|
WO2022261115A1
(en)
|
2021-06-07 |
2022-12-15 |
Yale University |
Peptide nucleic acids for spatiotemporal control of crispr-cas binding
|
WO2023056368A1
(en)
|
2021-09-30 |
2023-04-06 |
The United States Of America, As Represented By The Secretary, Department Of Health And Human Services |
Cyclic peptides as non-hormonal male contraceptive agents and methods of use thereof
|
WO2023148398A1
(en)
|
2022-02-07 |
2023-08-10 |
Var2 Pharmaceuticals Aps |
Antibodies and antibody fragments and analogues specific for chondroitin sulfate
|
WO2024039376A1
(en)
|
2022-08-18 |
2024-02-22 |
Elanco Us Inc. |
Method for improving growth performance in feedlot cattle
|